WRF Capital
Corporate VCSeattle · Pre-Seed–Series B · 21 people tracked
Investment thesis
WRF Capital invests roughly $5 million annually in Washington-based startups, focusing on spinouts from state nonprofit research institutions such as UW, WSU, Fred Hutch and ISB. It backs pre-seed through Series A companies across life sciences and enabling technologies, with initial checks of $100,000 to $2 million and reserves for follow-ons. Often the first money in, the firm partners with angels and VCs across rounds and can lead investments, syndicating with value-adding firms. It emphasizes rigorous due diligence and selective investing to help commercialize new technologies developed in Washington.
Source: firm website, verified Aug 3, 2026.
Team · 21 people
from the firm's website & curatedWhat they invest in
from 6 of 9 portfolio companiesBiotech ×4EdTech ×2Healthtech ×2AI & Machine Learning ×1Deep Tech ×1
HQs:United States×6
Investments · 9 tracked
founders shown can be your intro pathBy year:2026 · 12024 · 12015 · 13 dated
Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.
AI & Machine LearningBiotechDeep TechSeattle, US
Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)Hector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)
Co-investorsArgonautic VenturesColumbus Venture PartnersPack Ventures
Seattle, US
JACOB O. WOBBROCK(Executive Officer)WILLIAM T. COLLERAN(Executive Officer, Director)ANDREW KO(Executive Officer)
BoardWILLIAM MCALEER(Director)inMARK UPSON(Director)MICHAEL FRIDGEN(Director)
Co-investorsCowles VenturesThe W FundVoyager Capital
Automates complex call center operations; acquired by Sagility Health.
Co-investorsAllen Institute for AI (AI2) IncubatorFlare Capital PartnersRadical Ventures
Fred Hutch is a cancer treatment and research organization providing patient care, clinical trials, and research into the prevention, early detection, and treatment of cancer, HIV, and other diseases.
BiotechHealthtech
Proniras Corporation is a clinical-stage biotechnology company developing novel small-molecule therapeutics for substance use disorders and specialty central nervous system (CNS) conditions, including treatments for opioid withdrawal and seizure disorders.
BiotechHealthtechSeattle, US
CHRISTOPHER TOOMBS(Executive Officer)LINDSAY RAYLE(Executive Officer, Promoter)M. Johnston Erwin(Director)David Schubert(Executive Officer, Promoter)
BoardSTEVEN GILLIS(Director)inThong Le(Executive Officer, Director, Promoter)
Co-investorsACCELERATOR LIFE SCIENCE PARTNERSARCH Venture Partners
Biopharma company developing non-immunosuppressive drugs for autoimmune diseases.
Co-investorsNew Science VenturesEaston Capital
Washington State University is a public research university offering hundreds of degree programs across six campuses, with research and extension operations throughout Washington state.
EdTech
Portfolio news
latest coverage across their companiesFrequently asked questions
- What stage does WRF Capital invest at?
- WRF Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What is WRF Capital's typical check size?
- WRF Capital typically writes checks of $100K – $2M.
- What sectors does WRF Capital focus on?
- WRF Capital focuses on Biotech, Consumer, Data & Infrastructure, Deep Tech, Digital Health, Enterprise Software, Hardware, Healthtech, Medical Devices, New Materials, SaaS.
- Where is WRF Capital located?
- WRF Capital is headquartered in Seattle, US.
- Does WRF Capital lead rounds?
- Yes, WRF Capital leads investment rounds.
Co-investors · 1
Early-stage venture capital firm focused on digital health innovations including digital diagnostics, digital therapeutics, and tech-enabled services. Based in Boston and Philadelphia with deep clinical expertise and experience building and scaling healthcare ventures.
Firms observed investing alongside WRF Capital, from public investor directories. Shared companies are the overlap with WRF Capital's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Karista is a French venture capital firm that invests in tech and early-stage companies, frequently leading funding rounds and supporting founders through strategic guidance and board involvement.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
OMERS Ventures is a venture capital firm that invests in founders globally, with investment teams based in New York, Palo Alto, and Toronto.
























